304 related articles for article (PubMed ID: 36555288)
1. The Pan-Cancer Multi-Omics Landscape of FOXO Family Relevant to Clinical Outcome and Drug Resistance.
Xie J; Zhang J; Tian W; Zou Y; Tang Y; Zheng S; Wong CW; Deng X; Wu S; Chen J; Mo Y; Xie X
Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555288
[TBL] [Abstract][Full Text] [Related]
2. Comprehensive pan-cancer analysis of YBX family reveals YBX2 as a potential biomarker in liver cancer.
Yuan Z; Li B; Liao W; Kang D; Deng X; Tang H; Xie J; Hu D; Chen A
Front Immunol; 2024; 15():1382520. PubMed ID: 38698857
[TBL] [Abstract][Full Text] [Related]
3. FOXO transcription factors in cancer development and therapy.
Coomans de Brachène A; Demoulin JB
Cell Mol Life Sci; 2016 Mar; 73(6):1159-72. PubMed ID: 26686861
[TBL] [Abstract][Full Text] [Related]
4. The Pan-Cancer Landscape of Crosstalk Between TRP Family and Tumour Microenvironment Relevant to Prognosis and Immunotherapy Response.
Wu G; He M; Yin X; Wang W; Zhou J; Ren K; Chen X; Xue Q
Front Immunol; 2022; 13():837665. PubMed ID: 35493463
[TBL] [Abstract][Full Text] [Related]
5. The discrete roles of individual FOXO transcription factor family members in B-cell malignancies.
Lees J; Hay J; Moles MW; Michie AM
Front Immunol; 2023; 14():1179101. PubMed ID: 37275916
[TBL] [Abstract][Full Text] [Related]
6. FOXO family in regulating cancer and metabolism.
Ma J; Matkar S; He X; Hua X
Semin Cancer Biol; 2018 Jun; 50():32-41. PubMed ID: 29410116
[TBL] [Abstract][Full Text] [Related]
7. The pan-cancer multi-omics landscape of key genes of sialylation combined with RNA-sequencing validation.
Wu Z; Wang Z; Wu H; Zheng N; Huang D; Huang Z; Han H; Bao J; Xu H; Zhang R; Du Z; Wu D
Comput Biol Med; 2023 Nov; 166():107556. PubMed ID: 37801920
[TBL] [Abstract][Full Text] [Related]
8. FOXOs in cancer immunity: Knowns and unknowns.
Deng Y; Wang F; Hughes T; Yu J
Semin Cancer Biol; 2018 Jun; 50():53-64. PubMed ID: 29309928
[TBL] [Abstract][Full Text] [Related]
9. FOXOs: masters of the equilibrium.
Gui T; Burgering BMT
FEBS J; 2022 Dec; 289(24):7918-7939. PubMed ID: 34610198
[TBL] [Abstract][Full Text] [Related]
10. Multi-Omics Pan-Cancer Analysis of Procollagen N-Propeptidase Gene Family of ADAMTS as Novel Biomarkers to Associate with Prognosis, Tumor Immune Microenvironment, Signaling Pathways, and Drug Sensitivities.
Chen Y; Xiao C; Fan Q; Zhang Y; Huang Q; Ou Y
Front Biosci (Landmark Ed); 2024 Apr; 29(4):151. PubMed ID: 38682182
[TBL] [Abstract][Full Text] [Related]
11. Multi-omics analysis of N6-methyladenosine reader IGF2BP3 as a promising biomarker in pan-cancer.
Chen P; Xu J; Cui Z; Wu S; Xie T; Zhang X
Front Immunol; 2023; 14():1071675. PubMed ID: 36761737
[TBL] [Abstract][Full Text] [Related]
12. Diverse roles of FOXO family members in gastric cancer.
Chen YH; Li CL; Chen WJ; Liu J; Wu HT
World J Gastrointest Oncol; 2021 Oct; 13(10):1367-1382. PubMed ID: 34721771
[TBL] [Abstract][Full Text] [Related]
13. FOXO transcription factors as therapeutic targets in human diseases.
Orea-Soufi A; Paik J; Bragança J; Donlon TA; Willcox BJ; Link W
Trends Pharmacol Sci; 2022 Dec; 43(12):1070-1084. PubMed ID: 36280450
[TBL] [Abstract][Full Text] [Related]
14. Re-evaluating the role of FOXOs in cancer.
Hornsveld M; Dansen TB; Derksen PW; Burgering BMT
Semin Cancer Biol; 2018 Jun; 50():90-100. PubMed ID: 29175105
[TBL] [Abstract][Full Text] [Related]
15. Regulation and function of FoxO transcription factors in normal and cancer stem cells: what have we learned?
Zhang X; Rielland M; Yalcin S; Ghaffari S
Curr Drug Targets; 2011 Aug; 12(9):1267-83. PubMed ID: 21443463
[TBL] [Abstract][Full Text] [Related]
16. The "O" class: crafting clinical care with FoxO transcription factors.
Maiese K; Chong ZZ; Hou J; Shang YC
Adv Exp Med Biol; 2009; 665():242-60. PubMed ID: 20429429
[TBL] [Abstract][Full Text] [Related]
17. A pan-cancer analysis of the HER family gene and their association with prognosis, tumor microenvironment, and therapeutic targets.
Yang X; Miao Y; Wang J; Mi D
Life Sci; 2021 May; 273():119307. PubMed ID: 33691171
[TBL] [Abstract][Full Text] [Related]
18. The FOXO family of transcription factors: key molecular players in gastric cancer.
Liu Y; Ao X; Jia Y; Li X; Wang Y; Wang J
J Mol Med (Berl); 2022 Jul; 100(7):997-1015. PubMed ID: 35680690
[TBL] [Abstract][Full Text] [Related]
19. Immunological role and prognostic value of the SKA family in pan-cancer analysis.
Li Z; Huang L; Li J; Yang W; Li W; Long Q; Dai X; Wang H; Du G
Front Immunol; 2023; 14():1012999. PubMed ID: 37180139
[TBL] [Abstract][Full Text] [Related]
20. Role of Forkhead Box Class O proteins in cancer progression and metastasis.
Kim CG; Lee H; Gupta N; Ramachandran S; Kaushik I; Srivastava S; Kim SH; Srivastava SK
Semin Cancer Biol; 2018 Jun; 50():142-151. PubMed ID: 28774834
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
